CDK19 and its paralog CDK8 are known to promote different cancer-related pathways in several solid tumors, such as TGF-β/BMP-induced epithelial–mesenchymal-transition (EMT), and NFκB-mediated gene transcription [7,8,10,11]. This evidence concerns the gene CDK19 and cancer.